Axogen (AXGN) Liabilities and Shareholders Equity (2010 - 2026)

Axogen's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $289.5 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 47.57% year-over-year to $289.5 million; the TTM figure through Mar 2026 stood at $933.0 million (up 19.49% YoY), while the FY2025 annual figure was $221.7 million, up 8.82% from the prior year.
• Liabilities and Shareholders Equity was $289.5 million for Q1 2026 at Axogen, up from $221.7 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $289.5 million in Q1 2026 to a low of $186.5 million in Q1 2024.
• Historically, Liabilities and Shareholders Equity has averaged $203.4 million across 5 years, with a median of $196.1 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity dropped 6.88% in 2022, then soared 47.57% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $195.4 million in 2022, then gained by 0.74% to $196.8 million in 2023, then grew by 3.51% to $203.7 million in 2024, then gained by 8.82% to $221.7 million in 2025, then soared by 30.58% to $289.5 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $289.5 million (Q1 2026), $221.7 million (Q4 2025), and $216.4 million (Q3 2025), per Business Quant data.